Medtronic Increased Its Fiscal Year 2024 Adjusted EPS Guidance From Prior range Of $5.13-$5.19 To $5.19-$5.21 Versus Consensus Of $5.16
Portfolio Pulse from Benzinga Newsdesk
Medtronic has raised its adjusted EPS guidance for fiscal year 2024 from the previous range of $5.13-$5.19 to a new range of $5.19-$5.21, surpassing the consensus estimate of $5.16.

February 20, 2024 | 11:50 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Medtronic has updated its fiscal year 2024 adjusted EPS guidance, raising it above consensus estimates.
Raising the EPS guidance above consensus estimates typically signals confidence in the company's financial health and operational efficiency, which can positively influence investor sentiment and potentially lead to a short-term increase in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100